Ghrelin and the activated form of this peptide impact a number of obesity related pathways, including the regulation of appetite gain, energy metabolism, reward perception, the release of growth hormone and increased gastric secretion and motility [66]. This evidence concerns the gene GH1 and obesity due to melanocortin 4 receptor deficiency.